Close
Close

Ways and Means Committee votes to repeal medical device excise tax

RFP
Tax Hot Topics
Tax Hot TopicsThe House Ways and Means Committee approved a bill last week that would repeal the medical device excise tax. That legislation will go to the House floor the week of June 15.

The bill (H.R. 160) passed the committee by a 25‒14 vote, and is also expected to pass the full House. An earlier version would have repealed the tax retroactive to its inception in 2013, but the final bill approved by the committee would repeal the tax only for sales in quarters beginning after the date of enactment.

The House action represents only a small step toward repeal. The House has voted for full repeal in the past, yet the Senate and the White House present major obstacles. Even with Republicans controlling the Senate, they still need 60 votes to overcome filibusters and other procedural hurdles. Only one Democrat on the Ways and Means Committee, Ron Kind of Wisconsin, voted for repeal. More Democrats in the Senate may support repeal, but a vote would be close, with many Democrats objecting to the $25 billion cost. Senate Finance Committee Chair Orrin Hatch, R-Utah, said he didn’t think he could move the bill as stand-alone legislation, but would seek to attach it to other legislation.

If repeal survives the Senate, the White House still threatens a veto. The best hope for Republicans is likely through horse-trading with the president over other priorities or attaching the issue to a bill that is difficult for the president to veto.

Contact
Mel Schwarz
T +1 202 521 1564
E mel.schwarz@us.gt.com

Tax professional standards statement
This document supports Grant Thornton LLP’s marketing of professional services and is not written tax advice directed at the particular facts and circumstances of any person. If you are interested in the subject of this document, we encourage you to contact us or an independent tax adviser to discuss the potential application to your particular situation. Nothing herein shall be construed as imposing a limitation on any person from disclosing the tax treatment or tax structure of any matter addressed herein. To the extent this document may be considered to contain written tax advice, any written advice contained in, forwarded with or attached to this document is not intended by Grant Thornton LLP to be used, and cannot be used, by any person for the purpose of avoiding penalties that may be imposed under the Internal Revenue Code.

The information contained herein is general in nature and is based on authorities that are subject to change. It is not, and should not be construed as, accounting, legal or tax advice provided by Grant Thornton LLP to the reader. This material may not be applicable to, or suitable for, the reader’s specific circumstances or needs and may require consideration of tax and nontax factors not described herein. Contact Grant Thornton LLP or other tax professionals prior to taking any action based upon this information. Changes in tax laws or other factors could affect, on a prospective or retroactive basis, the information contained herein; Grant Thornton LLP assumes no obligation to inform the reader of any such changes. All references to “Section,” “Sec.,” or “§” refer to the Internal Revenue Code of 1986, as amended.